#4549
Alpha-Fetoprotein as a valuable biomarker in neuroendocrine tumours
Introduction:
Neuroendocrine tumours (NETs) are a rare group of tumours that pose a significant diagnostic, therapeutic, and prognostic challenge. This complexity arises from the diversity and heterogeneity of these neoplasms, as well as from the limitations of commonly used biomarkers in clinical practice. Alpha-fetoprotein (AFP) is a fetal protein widely used primarily for congenital defects in prenatal diagnostics and in certain malignancies in adults.
Conference:
Presenting Author:
Authors:
Musiałkiewicz J,
Gut P,
Komarnicki P,
Maciejewski A,
Ruchała M,
Keywords:
alpha-fetoprotein,
biomarker,
neuroendocrine tumour,
#4457
Primary mixed hepatocellular carcinoma-neuroendocrine carcinoma: A case report
Introduction:
Mixed epithelial neoplasms (MiNENs) are characterised by the coexistence of neuroendocrine and non-neuroendocrine components within a single tumour, each discernible histologically and immunohistochemically, with a minimum tumour proportion of 30%. Primary hepatic MiNENs are exceedingly rare entities.
Conference:
Presenting Author:
Tang Y
Authors:
Wang Y,
Wang R,
Yi X,
Guo M,
Tang Y,
Keywords:
pancreatic neuroendocrine tumour,
functional,
parathyroid hormone related peptide,
#2085
Alpha-Fetoprotein in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Single Centre Study
Introduction:
Several attempts to determine prognostic factors in neuroendocrine setting have been made, with inconsistent results until now. Alpha-fetoprotein (AFP) has previously been reported as being elevated in some neuroendocrine neoplasms (NENs), even if the actual clinical implications of this marker in this setting are unclear.
Conference:
15th Annual ENETSConcerence (2018)
Presenting Author:
Authors:
Rossi R,
Ciafardini C,
Conte D,
Massironi S,
Keywords:
alpha-fetoprotein,
neuroendocrine neoplasms,
biomarker,
prognosis,
